Medicare Part D plans and drug makers may apply to participate in a new payment model starting in January, which will allow plan sponsors to offer benefits that limit cost sharing for a 30-day supply of insulin to no more than $35. To encourage participation, the model will give qualifying plans that enroll a high number of insulin-dependent patients the option of additional risk corridor protection for calendar years 2021 and 2022. The model also will test how to encourage healthy behaviors and medication adherence through Part D reward and incentive programs. To participate, drug makers may apply through March 18 and Part D sponsors through May 1. CMS plans to make a list of participating drug makers available to Part D sponsors on or around March 20.

Related News Articles

Headline
Medicare open enrollment for 2026 began Oct. 15 and runs through Dec. 7. During the annual enrollment period, Medicare-eligible individuals can check their…
Headline
The AHA Oct. 3 responded to the Medicare Payment Advisory Commission’s recent analysis on the financial impacts of Medicare Advantage enrollment growth on…
Headline
The federal government shutdown will continue as the Senate Oct. 3 failed to adopt a government funding deal. The latest attempt to pass the House-passed…
Headline
The Centers for Medicare & Medicaid Services Sept. 30 issued a memo, through the Health Plan Management system, finalizing the Medicare Advantage…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure…